10:17 AM
Mar 07, 2019
 |  BC Innovations  |  Distillery Therapeutics

Blocking tumor-associated macrophage SIGLEC15 for solid tumors


INDICATION: Colorectal; melanoma; brain cancer; solid tumors

Patient sample, cell culture and mouse studies suggest inhibiting SIGLEC15 expressed on tumor-associated macrophages could help treat colorectal cancer, melanoma, glioblastoma and other solid tumors. In tissue samples from patients with colorectal cancer, bladder cancer, liver cancer, lung cancer or other solid tumors,...

Read the full 239 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >